Product Information
FEBUXOSTAT 40 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.2116 per EA under NDC 00904748403. Its NADAC has been published 97 times since Sep 25, 2024.
FDA first approved this application on Dec 30, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Febuxostat market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904748403
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA210461FDA Approved
12/30/2019
TE Code
AB
On Market Since
5/22/2024
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 40 MG TABLET has been published 97 times since Sep 25, 2024, and over the history we have for it it has declined 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2116 per EA |
|---|---|
| All-time high | $0.3998 (Nov 13, 2024) |
| All-time low | $0.2016 (Jan 21, 2026) |
| 52-week high | $0.2464 |
| 52-week low | $0.2016 |
| Median price | $0.2818 |
| Average price | $0.2868 |
| Largest weekly change | -16.8% (Jul 23, 2025) |
| Weeks tracked | 97 |
| Tracking since | Sep 25, 2024 |
1W
N/A
1M
N/A
3M
-0.6%
6M
+2.7%
1Y
-10.3%
3Y
N/A
5Y
N/A
All
-41.4%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Febuxostat market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Xanthine Oxidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 40 MG TABLET, manufactured by Major Pharmaceuticals, is $0.2116 per EA (NDC 00904748403), effective Jul 29, 2026.
How has the price of FEBUXOSTAT 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 40 MG TABLET has declined 41.4%. It has been tracked across 97 weekly CMS publications since Sep 25, 2024.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 40 MG TABLET?
Since Sep 25, 2024, the NADAC for FEBUXOSTAT 40 MG TABLET has ranged from a low of $0.2016 (Jan 21, 2026) to a high of $0.3998 (Nov 13, 2024), with a median of $0.2818 per EA.
Are there cheaper alternatives to FEBUXOSTAT 40 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FEBUXOSTAT 40 MG TABLET, is $0.1911 per EA — about 10% below FEBUXOSTAT 40 MG TABLET.
Who manufactures FEBUXOSTAT 40 MG TABLET?
FEBUXOSTAT 40 MG TABLET (NDC 00904748403) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.